Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)
TWSE
Closed
Aug 26, 2026
Day's Range
35.7552 wk Range
24.20Overview - 1762 - Chunghwa Chemical Synthesis & Biotech Co., Ltd.
Key Statistics
Valuation
Enterprise Value
2.42B
P/E (Trailing)
‪50.81‬
P/E (Forward)
‪80.44‬
PEG Ratio
‪0.04‬
Price / Sales (TTM)
‪2.98‬
Price / Book
‪0.62‬
EV / EBITDA
‪49.31‬
Profitability
Gross Margin
‪41.68%‬
Profit Margin
‪-5.53%‬
Operating Margin
‪11.55%‬
Return on Assets
‪-1.90%‬
Return on Equity
‪-1.60%‬
Ownership
Shares Outstanding
76.91M
Float
33.14M
Held by Insiders
‪41.27%‬
Held by Institutions
‪0.78%‬
Price stats
50-Day Avg
‪35.69‬
200-Day Avg
‪30.44‬
Dividends
Payout Ratio
‪145.45%‬
Frequency
Annual
Peers - 1762 - Chunghwa Chemical Synthesis & Biotech Co., Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on TWSE.
Profile Summary - 1762 - Chunghwa Chemical Synthesis & Biotech Co., Ltd.
About
Chunghwa Chemical Synthesis & Biotech Co., Ltd. is a prominent player in the pharmaceutical and biotechnology industry, primarily focused on the development, manufacture, and distribution of high-quality chemical synthesis products and biotech solutions. Its operations span from producing active pharmaceutical…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
